Gemtesa (vibegron) is a brand-name drug prescribed for adults with overactive bladder. It is an oral tablet typically taken once daily. The typical dosage of Gemtesa is 75 mg once daily, but the ...
The price of Gemtesa 75-milligram tablets can vary based on your insurance coverage, treatment plan, and pharmacy. The cost with insurance may be lower than the cost without insurance coverage. Your ...
Gemtesa’s manufacturer (Urovant Sciences) provides the Gemtesa Simple Savings Program. This is a financial assistance plan aimed at making Gemtesa (vibegron) — a treatment for overactive bladder in ...
OAB is commonly treated with a class of medicines called anticholinergics or antimuscarinics. These medicines block chemicals in your body that help the bladder to squeeze. By blocking these chemicals ...
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ...
IRVINE, Calif. & BASEL, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Urovant Sciences, Inc. and Sunovion Pharmaceuticals Inc. today announced the launch of co-promotion activities for GEMTESA® ...
Gemtesa is used to treat urinary urgency, frequency, and incontinence caused by an overactive bladder in adults. This includes certain males with benign prostatic hyperplasia (BPH). Digoxin (Lanoxin) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback